Lisa Heinzerling, a professor of law at Georgetown University, argued this year in the Vermont Law Review that the FDA is facing a "moment of truth," a moment when "an administrative agency must confront evidence concerning a social problem it is charged with addressing, and speak the truth, as best it can, about it."
[